| ≥1 piece |
Betapol has been developed in order to overcome the problems associated with poor fatty acid absorption from infant formula and the negative consequences of this on energy supply, stool consistency and bone development.
Studies in animals and newborn babies have confirmed that all the fatty acids in Betapol - including palmitic acid - are well absorbed into the bloodstream, and that only tiny quantities are lost in the feces. This greatly improves the absorption of dietary calcium and significantly reduces the amount of calcium lost in the stools. This, in turn, produces softer stools and a greater bone mineral density.
Stool consistency and bone mineral density in babies who receive Betapol are comparable to those seen breast-fed babies.